DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,626,711 | +24.2% | 46,863 | +20.2% | 0.05% | +25.0% |
Q2 2023 | $9,357,600 | -36.0% | 38,990 | -32.8% | 0.04% | -39.4% |
Q1 2023 | $14,621,092 | -10.3% | 58,011 | -5.5% | 0.07% | -16.5% |
Q4 2022 | $16,293,868 | -24.4% | 61,389 | -26.5% | 0.08% | -31.3% |
Q3 2022 | $21,564,000 | +12.2% | 83,486 | +10.1% | 0.12% | +18.6% |
Q2 2022 | $19,216,000 | -6.1% | 75,796 | +8.6% | 0.10% | +7.8% |
Q1 2022 | $20,470,000 | +3.2% | 69,788 | +15.7% | 0.09% | +7.1% |
Q4 2021 | $19,842,000 | +18.8% | 60,309 | +10.0% | 0.08% | +9.1% |
Q3 2021 | $16,696,000 | +25.2% | 54,841 | +10.4% | 0.08% | +22.2% |
Q2 2021 | $13,332,000 | +30.1% | 49,681 | +9.1% | 0.06% | +14.5% |
Q1 2021 | $10,247,000 | +6.3% | 45,528 | +4.9% | 0.06% | -5.2% |
Q4 2020 | $9,638,000 | +6.6% | 43,388 | +3.4% | 0.06% | -10.8% |
Q3 2020 | $9,039,000 | +22.0% | 41,976 | +0.2% | 0.06% | +14.0% |
Q2 2020 | $7,411,000 | +36.6% | 41,908 | +6.9% | 0.06% | +16.3% |
Q1 2020 | $5,424,000 | +5.8% | 39,187 | +17.3% | 0.05% | +28.9% |
Q4 2019 | $5,128,000 | +6.6% | 33,411 | +0.3% | 0.04% | -5.0% |
Q3 2019 | $4,812,000 | +2.3% | 33,317 | +1.2% | 0.04% | -2.4% |
Q2 2019 | $4,703,000 | +14.4% | 32,909 | +5.7% | 0.04% | +7.9% |
Q1 2019 | $4,111,000 | +32.7% | 31,140 | +3.6% | 0.04% | +15.2% |
Q4 2018 | $3,099,000 | – | 30,055 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |